Summary
Utahns who have taken the antidepressant drug Remeron may be eligible for monetary compensation as part of a $36 million settlement announced by the Utah Attorney General's Office.
Spokesman Paul Murphy said the suit against manufacturer Organon USA Inc. and its parent company, Akzo Nobel N.V., was brought by attorneys general in all 50 states after Organon allegedly blocked cheaper generic versions of the drug.See the full content of this document
Extract
Drug Settlement Declared
Organon was accused of misleading the Food and Drug Administ...
See the full content of this document
Sponsored links
